Tern Q&A: Talking Medicines investment providing synergies across the portfolio (LON:TERN) 11 November 2020
Touchstone Exploration Q&A “very, very busy news flow over the next 90 days” (LON:TXP) 6 November 2020
N4 Pharma could attract a corporate partner far earlier than expected says SP Angel (Analyst Interview)
Allergy Therapeutics Excellent performance shown in FH1’17 Interim results – Zeus Capital 29 March 2017
TEAM plc CIO Flags 20% Plus Returns, AI Capex Doubts and Looming Inflation Shock (Video) 16 February 2026
Diverse Income Trust Plc reports 8.5% H1 returns and review of redemptions and discount 13 February 2026
Smithson Investment Trust PLC (SSON.L) Stock Analysis: Navigating a 52-Week Range with Strategic Asset Management 19 February 2026
Sequoia Economic Infrastructure (SEQI.L) Investor Outlook: Navigating a High Dividend Yield with 9.36% Upside Potential 19 February 2026
Edinburgh Investment Trust PLC (EDIN.L) Stock Analysis: A Deep Dive into Performance and Dividend Yield 19 February 2026
Tern Q&A: Talking Medicines investment providing synergies across the portfolio (LON:TERN) 11 November 2020
Touchstone Exploration Q&A “very, very busy news flow over the next 90 days” (LON:TXP) 6 November 2020
N4 Pharma could attract a corporate partner far earlier than expected says SP Angel (Analyst Interview)
Allergy Therapeutics Excellent performance shown in FH1’17 Interim results – Zeus Capital 29 March 2017
TEAM plc CIO Flags 20% Plus Returns, AI Capex Doubts and Looming Inflation Shock (Video) 16 February 2026
Diverse Income Trust Plc reports 8.5% H1 returns and review of redemptions and discount 13 February 2026
Smithson Investment Trust PLC (SSON.L) Stock Analysis: Navigating a 52-Week Range with Strategic Asset Management 19 February 2026
Sequoia Economic Infrastructure (SEQI.L) Investor Outlook: Navigating a High Dividend Yield with 9.36% Upside Potential 19 February 2026
Edinburgh Investment Trust PLC (EDIN.L) Stock Analysis: A Deep Dive into Performance and Dividend Yield 19 February 2026
Insmed Incorporated (INSM) Stock Analysis: Exploring Growth Potential in Biotechnology with a 52.4% Revenue Surge 1 December 2025
IQVIA Holdings, Inc. (IQV) Stock Analysis: A Healthcare Giant with an 8% Upside Potential 1 December 2025
McKesson Corporation (MCK) Stock Analysis: Navigating Opportunities in Healthcare with a 6.09% Potential Upside 1 December 2025
Doximity, Inc. (DOCS): Investor Outlook with a 33% Upside Potential and Strong Market Position 1 December 2025
Exelixis, Inc. (EXEL) Stock Analysis: Strong Buy Ratings and Promising Growth in Oncology 1 December 2025
Fresenius Medical Care AG (FMS) Stock Analysis: Exploring a 23% Upside Potential Amidst Healthcare Sector Dynamics 1 December 2025
Bio-Rad Laboratories, Inc. (BIO): Investor Outlook on Potential Upside and Market Position 1 December 2025
Waystar Holding Corp. (WAY) Stock Analysis: Navigating a 33% Potential Upside in the Healthcare Information Sector 1 December 2025
Royalty Pharma plc (RPRX) Stock Analysis: Discovering the 14.90% Potential Upside for Investors 1 December 2025
BridgeBio Pharma, Inc. (BBIO) Stock Analysis: A Biotech Powerhouse with 17.55% Upside Potential 1 December 2025
Bio-Techne Corp (TECH) Stock Analysis: Exploring a 7.22% Potential Upside Amidst Market Volatility 1 December 2025
Baxter International Inc. (BAX) Stock Analysis: Navigating Challenges with a 28.42% Potential Upside 1 December 2025
Insulet Corporation (PODD) Investor Outlook: Promising 15.59% Upside Amid Robust Growth 1 December 2025
Humana Inc. (HUM) Stock Analysis: Navigating Healthcare Challenges with a 16.62% Upside Potential 1 December 2025
Quest Diagnostics (DGX) Stock Analysis: Navigating Healthcare Diagnostics with a 4.3% Upside Potential 1 December 2025
Corcept Therapeutics (CORT) Stock Report: Exploring a 70% Potential Upside in the Biotech Sector 1 December 2025
Agilent Technologies, Inc. (A): Investor Outlook on a Healthcare Powerhouse with a 9% Upside Potential 1 December 2025
Align Technology, Inc. (ALGN) Stock Analysis: Exploring Growth Potential with a 25% Upside 1 December 2025
Exact Sciences Corporation (EXAS) Stock Analysis: Exploring the Growth Potential in the Diagnostics Sector 1 December 2025
Avacta Group make significant progress with its highly scalable lateral flow test (Interview) 23 November 2020
Non-Standard Finance profits and profitability could increase sharply (Analyst Interview) 23 November 2020
Tatton Asset Management set to grow and deliver an attractive dividend (Analyst Interview) 20 November 2020
N4 Pharma could attract a corporate partner far earlier than expected says SP Angel (Analyst Interview) 19 November 2020
Tern Q&A: Talking Medicines investment providing synergies across the portfolio (LON:TERN) 11 November 2020
Touchstone Exploration Q&A “very, very busy news flow over the next 90 days” (LON:TXP) 6 November 2020
Allergy Therapeutics Excellent performance shown in FH1’17 Interim results – Zeus Capital 29 March 2017
TEAM plc CIO Flags 20% Plus Returns, AI Capex Doubts and Looming Inflation Shock (Video) 16 February 2026
Diverse Income Trust Plc reports 8.5% H1 returns and review of redemptions and discount 13 February 2026
Smithson Investment Trust PLC (SSON.L) Stock Analysis: Navigating a 52-Week Range with Strategic Asset Management 19 February 2026
Sequoia Economic Infrastructure (SEQI.L) Investor Outlook: Navigating a High Dividend Yield with 9.36% Upside Potential 19 February 2026
Edinburgh Investment Trust PLC (EDIN.L) Stock Analysis: A Deep Dive into Performance and Dividend Yield 19 February 2026
